Demodicidosis
MONDO:0017280Demodicidosis is a rare parasitic cutaneous disease due to Demodex mite infestation characterized by variable degrees of spinulosis, erythema, papules, and pustules, usually accompanied by a burning or pruritic sensation. Face (incl. eyelids) is most frequently affected, but ear canal, scalp, neck, back, chest, nipples, buttocks, penis, and extremity (legs and arms) involvement have also been observed. Dermoscopic examination reveals Demodex tails and follicular openings.
Also known as: Demodex caused disease or disorder, Demodex disease or disorder, Demodex infectious disease, Demodicosis, demodectic mange, red mange
7 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
NIH opens study to treat parasitic infections like malaria and worms
Disease control Recruiting nowThis study at the National Institutes of Health evaluates and treats people aged 3 and older with known or suspected parasitic infections, such as malaria, intestinal worms, and others. Participants receive standard medical care, not experimental treatments. The goal is to monito…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New eye drop takes on pesky eyelash mites
Disease control Recruiting nowThis study tests an experimental eye drop called GLK-321 in 250 adults with Demodex blepharitis, a condition where tiny mites cause debris at the base of eyelashes. Participants will receive either a low, mid, or high dose of the drug, or a placebo, for 6 weeks. The main goal is …
Phase: PHASE2 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can colored light masks soothe dry, irritated eyes?
Symptom relief Recruiting nowThis study compares red and blue light therapy masks for people with dry eye disease, meibomian gland dysfunction, and blepharitis (eyelid inflammation). Thirty-six participants will receive three light treatments, one week apart, and be followed for one month after the last sess…
Phase: NA • Sponsor: Aston University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC